Samuel Brusco, Associate Editor09.23.22
Dentsply Sirona has appointed Glenn Coleman as its new executive VP and chief financial officer (CFO), succeeding Barbara Bodem who has been interim CFO since May.
Bodem was appointed CFO in the wake of departing CFO Jorge Gomez’ move to Moderna. Gomez left his CFO position at Moderna after six days, following Dentsply’s May 10 disclosure of internal investigation into financial reporting matters.
Coleman was most recently executive VP and chief operating officer (COO) of Integra LifeSciences. Before Integra, he had financial positions at businesses including Curtiss-Wright Corporation and Alcatel-Lucent.
Simon Campion, newly appointed CEO of Dentsply Sirona, told the press, “We are pleased to have Glenn join us in the CFO role. He is a transformational leader with a strong history of driving value creation and sustainable growth. Over the course of his career, he has overseen financial and operational functions across several geographies and industries, including healthcare. Glenn, like me, is a high-integrity leader who shares our commitment to accountability, operational rigor, discipline, and execution. I have no doubts that he will be a great thought partner for me and the other members of the leadership team. Glenn’s leadership will be instrumental as we move forward with the previously announced review of the Company’s business and operations including competitive positioning and portfolio, margin enhancement opportunities, and capital structure.”
Coleman said, “I’m excited to join Dentsply Sirona as the Company prepares to enter its next chapter. I look forward to working with Simon and rest of the team to bring greater focus and discipline to our execution, advance our financial, operational, and strategic goals, and ultimately deliver long-term growth and value creation.”
Bodem was appointed CFO in the wake of departing CFO Jorge Gomez’ move to Moderna. Gomez left his CFO position at Moderna after six days, following Dentsply’s May 10 disclosure of internal investigation into financial reporting matters.
Coleman was most recently executive VP and chief operating officer (COO) of Integra LifeSciences. Before Integra, he had financial positions at businesses including Curtiss-Wright Corporation and Alcatel-Lucent.
Simon Campion, newly appointed CEO of Dentsply Sirona, told the press, “We are pleased to have Glenn join us in the CFO role. He is a transformational leader with a strong history of driving value creation and sustainable growth. Over the course of his career, he has overseen financial and operational functions across several geographies and industries, including healthcare. Glenn, like me, is a high-integrity leader who shares our commitment to accountability, operational rigor, discipline, and execution. I have no doubts that he will be a great thought partner for me and the other members of the leadership team. Glenn’s leadership will be instrumental as we move forward with the previously announced review of the Company’s business and operations including competitive positioning and portfolio, margin enhancement opportunities, and capital structure.”
Coleman said, “I’m excited to join Dentsply Sirona as the Company prepares to enter its next chapter. I look forward to working with Simon and rest of the team to bring greater focus and discipline to our execution, advance our financial, operational, and strategic goals, and ultimately deliver long-term growth and value creation.”